Coach, Inc. (NYSE:COH) reported net sales of $1.00 billion for its fourth fiscal quarter ended June 27, 2015, including a $43 million contribution from the May acquisition of Stuart Weitzman. This compared with $1.14 billion reported in the same period of the prior year, a decrease of 12%. On a constant currency basis, total sales declined 8% for the period. Net income for the quarter totaled $85 million, with earnings per diluted share of $0.31, excluding transformation-related charges and acquisition costs. Coach, Inc. (NYSE:COH) belongs to Consumer Goods sector. Its net profit margin is 10.80% and weekly performance is 1.72%. On last trading day company shares ended up $31.41. Coach, Inc. (NYSE:COH) distance from 50-day simple moving average (SMA50) is -7.77%.
XBiotech, Inc. (NASDAQ:XBIT) provided a corporate and clinical update for the second quarter ended June 30, 2015. This marks XBiotech’s first time hosting a quarterly investor call and it provides an opportunity to review the significant accomplishments achieved during the Company’s first full quarter as a public company. Complete enrollment in the European Phase 3 colorectal cancer study in the third quarter 2015; report top-line data late 2015 or early 2016,Report results from Phase 1/2 study of 514G3 therapeutic antibody against S. aureus in first quarter 2016,Complete enrollment and report interim data for global Phase 3 Xilonix study in late 2016, Complete construction of new manufacturing and begin operations in the second quarter 2016. XBiotech, Inc. (NASDAQ:XBIT) shares decreased -9.50% in last trading session and ended the day at $15.82. Its return on assets is -90.40%. XBiotech, Inc. (NASDAQ:XBIT) quarterly performance is -13.08%.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Discloses Insider Transaction. Glenn Goddard , Senior Vice President, Finance of Agios Pharmaceuticals Inc sold 7,000 shares on Jul 23, 2015. The Insider selling transaction was disclosed on Jul 27, 2015 to the Securities and Exchange Commission. The shares were sold at $120.45 per share for a total value of $843,150.00. On 04 August, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares increased 0.19% and was closed at $111.12. AGIO EPS growth in last 5 year was 0.00%. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) year to date (YTD) performance is -0.82%.
The Allstate Corporation (NYSE:ALL) reported second-quarter 2015 operating earnings per share of 63 cents, which widely missed the Zacks Consensus Estimate of 94 cents. Also, the reported earnings declined from the year-ago quarter figure of $1.01. The Allstate Corporation (NYSE:ALL) ended the last trading day at $62.34. Company weekly volatility is calculated as 1.91% and price to cash ratio as 27.84. The Allstate Corporation (NYSE:ALL) showed a weekly performance of -9.10%.
Essex Property Trust Inc. (NYSE:ESS) host a conference call at 2:00 PM ET on July 31, 2015, to discuss Q2 15 earnings results.Essex Property Trust Inc. (NYSE:ESS) shares decreased -0.55% in last trading session and ended the day at $225.31. ESS Gross Margin is 68.30% and its return on assets is 1.50%. Essex Property Trust Inc. (NYSE:ESS) quarterly performance is 3.43%.